Glucocorticoids (GCs) have been the mainstay of immunosuppressive therapy in solid organ
transplantation (SOT) for decades, due to their potent effects on innate immunity and tissue …

Abstract Purpose of Review Artificial intelligence (AI), machine learning, and technology-
enabled remote patient care have evolved rapidly and have now been incorporated into …

Long‐term survival for children who undergo LT is now the rule rather than the exception.
However, a focus on the outcome of patient or graft survival rates alone provides an …

The use of induction immunosuppression in liver transplantation (LT) remains controversial.
This was a retrospective cohort study of adult, first-time liver-alone recipients (N= 69 349) at …

Background. Weight gain and obesity are well-known clinical issues in liver transplantation
(LTx). However, their impacts on patient outcomes remain unclear, as only the impact of pre …

Background. Immunosuppression is a critical aspect of post-transplant management, yet
practices at intermediate and late time points after liver transplantation (LT) are poorly …

There are no established regulations governing patient selection for simultaneous heart‐
kidney (SHK) transplantation, creating the potential for significant center‐level variations in …

Background There is extensive literature with comparisons between Anti-Thymocyte
Globulin (ATG) and Basiliximab (BSX) as induction therapy in kidney transplant recipients …

The first liver transplant, performed by Dr Thomas Starzl in 1967, used a combination of
azathioprine, steroids, and heterolygous antilymphocyte globulin (ALG) for …

This review discusses long-term complications from immunosuppressants after liver
transplantation and the management of these complications. Common complications of …